SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-066031
Filing Date
2017-11-03
Accepted
2017-11-03 16:05:38
Documents
60
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-20638_110q.htm 10-Q 1060834
2 EX-31.1 a17-20638_1ex31d1.htm EX-31.1 9745
3 EX-31.2 a17-20638_1ex31d2.htm EX-31.2 10229
4 EX-32 a17-20638_1ex32.htm EX-32 9824
  Complete submission text file 0001104659-17-066031.txt   5242751

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT inva-20170930.xml EX-101.INS 1183950
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inva-20170930.xsd EX-101.SCH 48346
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inva-20170930_cal.xml EX-101.CAL 60492
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inva-20170930_def.xml EX-101.DEF 166371
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT inva-20170930_lab.xml EX-101.LAB 411780
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inva-20170930_pre.xml EX-101.PRE 303383
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 171176440
SIC: 2834 Pharmaceutical Preparations